Boland Jennifer M, Folpe Andrew L
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Hum Pathol. 2016 Nov;57:13-16. doi: 10.1016/j.humpath.2016.05.026. Epub 2016 Jun 23.
Malignant gastrointestinal neuroectodermal tumor (MGNET) is a very rare, aggressive malignant neoplasm that may occur in any location in the gastrointestinal tract. Malignant gastrointestinal neuroectodermal tumors typically consist of sheet-like to pseudopapillary proliferation of primitive-appearing epithelioid cells with a moderate amount of lightly eosinophilic cytoplasm, round nuclei and small nucleoli, often in association with osteoclast-like giant cells. By immunohistochemistry, these tumors show expression of S100 protein and SOX10, in the absence of expression of more specific melanocytic markers (eg, HMB45, Melan A). Genetically, malignant gastrointestinal neuroectodermal tumors are characterized by rearrangements of the EWSR1 or FUS genes with CREB1 or ATF1. We report a case of gastric malignant gastrointestinal neuroectodermal tumor occurring in a 46-year-old woman and showing striking oncocytic cytoplasmic change, a previously undescribed potential diagnostic pitfall. An initial needle biopsy showed large, eosinophilic cells with S100 protein and SOX10 expression and lacking expression of KIT, DOG1, Melan A, keratin, chromogranin, or smooth muscle actin, and was interpreted as representing a granular cell tumor. The subsequent excision specimen showed similar-appearing areas, but also contained small more primitive-appearing areas, lacking oncocytic change and having high nuclear grade and brisk mitotic activity. This resection specimen was initially diagnosed as a malignant granular cell tumor. However subsequent gene expression profiling studies showed an EWSR1-ATF1 fusion, confirmed with fluorescence in situ hybridization for EWSR1, and a final diagnosis of MGNET with oncocytic change was made. This case highlights a previously undescribed pitfall in the diagnosis of MGNET, oncocytic change, and suggests that MGNET should be included in the differential diagnosis for unusual oncocytic neoplasms of the gastrointestinal tract.
恶性胃肠道神经外胚层肿瘤(MGNET)是一种非常罕见的侵袭性恶性肿瘤,可发生于胃肠道的任何部位。恶性胃肠道神经外胚层肿瘤通常由外观原始的上皮样细胞呈片状至假乳头状增生组成,具有中等量轻度嗜酸性细胞质、圆形细胞核和小核仁,常伴有破骨细胞样巨细胞。通过免疫组织化学,这些肿瘤显示S100蛋白和SOX10表达,而缺乏更特异性黑素细胞标志物(如HMB45、Melan A)的表达。在基因方面,恶性胃肠道神经外胚层肿瘤的特征是EWSR1或FUS基因与CREB1或ATF1发生重排。我们报告一例发生在一名46岁女性的胃恶性胃肠道神经外胚层肿瘤,该肿瘤显示出显著的嗜酸性细胞质改变,这是一个以前未描述过的潜在诊断陷阱。最初的针吸活检显示大的嗜酸性细胞,有S100蛋白和SOX10表达,缺乏KIT、DOG1、Melan A、角蛋白、嗜铬粒蛋白或平滑肌肌动蛋白表达,被解释为代表颗粒细胞瘤。随后的切除标本显示有类似区域,但也包含一些更小的外观更原始的区域,没有嗜酸性改变,具有高核分级和活跃的有丝分裂活性。这个切除标本最初被诊断为恶性颗粒细胞瘤。然而,随后的基因表达谱研究显示有EWSR1-ATF1融合,通过EWSR1荧光原位杂交得以证实,最终诊断为伴有嗜酸性改变的MGNET。该病例突出了MGNET诊断中一个以前未描述过的陷阱——嗜酸性改变,并提示MGNET应纳入胃肠道不寻常嗜酸性肿瘤的鉴别诊断。